[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1065572, "exercisedValue": 0, "unexercisedValue": 341267}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 61, "title": "President & COO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 777048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 747017, "exercisedValue": 30004, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 767825, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 2597639, "exercisedValue": 0, "unexercisedValue": 1357712}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.72, "open": 6.73, "dayLow": 6.47, "dayHigh": 6.8, "regularMarketPreviousClose": 6.72, "regularMarketOpen": 6.73, "regularMarketDayLow": 6.47, "regularMarketDayHigh": 6.8, "payoutRatio": 0.0, "beta": 0.945, "forwardPE": -29.59091, "volume": 1963223, "regularMarketVolume": 1963223, "averageVolume": 2388792, "averageVolume10days": 1884710, "averageDailyVolume10Day": 1884710, "bid": 4.87, "ask": 8.53, "bidSize": 2, "askSize": 2, "marketCap": 1080167168, "fiftyTwoWeekLow": 3.14, "fiftyTwoWeekHigh": 10.08, "allTimeHigh": 27.98, "allTimeLow": 0.97, "priceToSalesTrailing12Months": 4.0586886, "fiftyDayAverage": 8.1164, "twoHundredDayAverage": 6.0843, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1246223104, "profitMargins": -0.058769997, "floatShares": 158613665, "sharesOutstanding": 165924289, "sharesShort": 15746194, "sharesShortPriorMonth": 17850615, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0949, "heldPercentInsiders": 0.03953, "heldPercentInstitutions": 0.59414, "shortRatio": 5.22, "shortPercentOfFloat": 0.0986, "impliedSharesOutstanding": 165924289, "bookValue": -0.005, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -15640000, "trailingEps": -0.1, "forwardEps": -0.22, "enterpriseToRevenue": 4.683, "enterpriseToEbitda": 44.451, "52WeekChange": 0.8033241, "SandP52WeekChange": 0.13506866, "quoteType": "EQUITY", "currentPrice": 6.51, "targetHighPrice": 18.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.5, "targetMedianPrice": 10.5, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 91598000, "totalCashPerShare": 0.552, "ebitda": 28036000, "totalDebt": 257654000, "quickRatio": 1.251, "currentRatio": 1.928, "totalRevenue": 266136992, "revenuePerShare": 1.704, "returnOnAssets": 0.02875, "grossProfits": 225036992, "freeCashflow": 28553500, "operatingCashflow": 10558000, "revenueGrowth": 0.371, "grossMargins": 0.84556997, "ebitdaMargins": 0.105340004, "operatingMargins": 0.09049, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "averageDailyVolume3Month": 2388792, "fiftyTwoWeekLowChange": 3.3700001, "fiftyTwoWeekLowChangePercent": 1.0732484, "fiftyTwoWeekRange": "3.14 - 10.08", "fiftyTwoWeekHighChange": -3.5699997, "fiftyTwoWeekHighChangePercent": -0.35416663, "fiftyTwoWeekChangePercent": 80.33241, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.1, "epsForward": -0.22, "epsCurrentYear": -0.04, "priceEpsCurrentYear": -162.75002, "fiftyDayAverageChange": -1.6063995, "fiftyDayAverageChangePercent": -0.1979202, "twoHundredDayAverageChange": 0.4257002, "twoHundredDayAverageChangePercent": 0.069966994, "priceToBook": -1302.0001, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-12-05", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "marketState": "CLOSED", "regularMarketPrice": 6.51, "corporateActions": [], "postMarketTime": 1764980262, "regularMarketTime": 1764968400, "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.12499, "postMarketChangePercent": 1.9969221, "postMarketPrice": 6.64, "postMarketChange": 0.12999964, "regularMarketChange": -0.21, "regularMarketDayRange": "6.47 - 6.8", "fullExchangeName": "NasdaqGS", "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]